Home » Stocks » MACK

Merrimack Pharmaceuticals, Inc. (MACK)

Stock Price: $6.43 USD 0.02 (0.31%)
Updated Jun 11, 2021 4:00 PM EDT - Market closed
After-hours: $6.30 -0.13 (-2.02%) Jun 11, 6:39 PM
Market Cap 86.23M
Revenue (ttm) n/a
Net Income (ttm) -3.97M
Shares Out 13.41M
EPS (ttm) -0.30
PE Ratio n/a
Forward PE n/a
Dividend $1.50
Dividend Yield 23.28%
Trading Day June 11
Last Price $6.43
Previous Close $6.41
Change ($) 0.02
Change (%) 0.31%
Day's Open 6.41
Day's Range 6.37 - 6.48
Day's Volume 10,707
52-Week Range 3.07 - 9.45

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Reports Full Year 2020 Financial Results

3 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Pharmaceuticals Q3 2020 Earnings Release

7 months ago - Business Wire

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Merrimack Reports Second Quarter 2020 Financial Results

10 months ago - Business Wire

Merrimack Pharmaceuticals: SCLC Presents A Lower Hurdle For Approval Than Initially Assumed

1 year ago - Seeking Alpha

Merrimack Pharmaceuticals - A Better Way To Invest In Biotechnology

1 year ago - Seeking Alpha

Merrimack Pharmaceuticals is a special-situations investment.

1 year ago - Seeking Alpha

Merrimack Pharmaceuticals Inc. has announced that it will be discontinuing one of its cancer drugs, as well as conducting layoffs.

2 years ago - 24/7 Wall Street

About MACK

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was founded in 1993 and is headquartered in Cambridge, Massachusetts.

Industry
Biotechnology
IPO Date
Mar 29, 2012
Stock Exchange
NASDAQ
Ticker Symbol
MACK
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for MACK is 4.00, which is a decrease of -37.79% from the latest price.

Price Target
$4.00
(-37.79% downside)